|
| Press Releases |
|
 |
|
| Tuesday, March 16, 2021 |
|
|
Eisai: Anti-MTBR (Microtubule Binding Region) Tau Antibody E2814 is Selected on Clinical Study for Dominantly Inherited Alzheimer's Disease by Dian-Tu |
| Eisai Co., Ltd. announced today that anti-microtubule binding region (MTBR) tau antibody E2814, which was created from collaboration research between Eisai and University College London, has been selected by the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU). more info >> |
|
| Friday, March 12, 2021 |
|
|
Eisai: Ministry of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anti-Cancer Agent Lenvima (Lenvatinib) With Prospective Indication for Uterine Body Cancer |
| Eisai Co., Ltd. announced today that it has received orphan drug designation for LENVIMA (generic name: lenvatinib mesylate), the orally available multiple receptor kinase inhibitor discovered by Eisai, with a prospective indication for uterine body cancer, by the Ministry of Health, Labour and Welfare (MHLW). more info >> |
|
| Friday, March 5, 2021 |
|
|
Eisai to Present Latest Data on Pipeline Assets in the Area of Alzheimer's Disease and Dementia at the 15th International Conference on Alzheimer's and Parkinson's Disease |
| Eisai Co., Ltd. announced today that the latest data from its Alzheimer's disease (AD) and dementia pipeline, including the investigational anti-amyloid beta protofibril antibody lecanemab, will be presented at the 15th International Conference on Alzheimer's and Parkinson's Disease (AD/PD2021) to be held virtually from March 9 to 14, 2021. more info >> |
|
| Thursday, March 4, 2021 |
|
|
Eisai to Support Construction of Screening Framework for the Novel Coronavirus Infection in Kenya |
| Eisai Co., Ltd. announced today that it has decided to assent to and support a project led by CA Medlynks Kenya, Ltd., a subsidiary of the healthcare startup company engaged in improving healthcare access in Africa, Connect Afya Co., Ltd., which aims to build a new structure for the efficient testing framework for the novel coronavirus infection in Kenya. more info >> |
|
| Tuesday, March 2, 2021 |
|
|
New Drug Approval for in-House Developed Anti-Insomnia Drug Dayvigo (Lemborexant) in Hong Kong |
| Eisai Co., Ltd. announced that its Hong Kong subsidiary Eisai (Hong Kong) Co., Ltd. has obtained approval for the in-house-discovered and developed orexin receptor antagonist DAYVIGO (generic name: lemborexant) for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. more info >> |
|
| Monday, February 22, 2021 |
|
|
Eisai: MHLW Grants Orphan Drug Designation in Japan to Novel FGF Receptor Selective Tyrosine Kinase Inhibitor E7090 |
| Eisai Co., Ltd. announced that it has received orphan drug designation for a prospective indication for unresectable biliary tract cancer with FGFR2 gene fusion by the Ministry of Health, Labour and Welfare, Japan (MHLW) for its in-house discovered fibroblast growth factor (FGF) receptor (FGFR1, FGFR2, FGFR3) selective tyrosine kinase inhibitor E7090, which is currently under development as an orally available novel anti-cancer agent. more info >> |
|
|
Eisai Receives Corporate Philanthropy Award for Its Efforts to Realize Human Health Care (hhc) Philosophy |
| Eisai Co., Ltd. announced today that it has received the 18th Corporate Philanthropy Award (FY 2020) of the Japan Philanthropic Association. The presentation ceremony was held on February 19, 2021 (Friday) at the GakushiKaikan (Chiyoda-ku, Tokyo). more info >> |
|
| Monday, February 15, 2021 |
|
|
LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Demonstrated Superior Progression-Free Survival (PFS) and Overall Survival (OS) Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma |
| Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United States and Canada) today announced the first presentation of new investigational data from the pivotal Phase 3 CLEAR study (Study 307/KEYNOTE-581) in an oral presentation session (Abstract #269) at the virtual 2021 Genitourinary Cancers Symposium (ASCO GU) and simultaneously published in the New England Journal of Medicine. more info >> |
|
| Wednesday, February 3, 2021 |
|
|
Two Immigrants, One Unique Plan For A Biopharma |
| The American Dream is why the United States is considered the "land of opportunity," and why for centuries immigrants have flocked to our shores seeking their fortunes. Sanjeev Redkar, Ph.D., (India) and Guo-Liang Yu, Ph.D., (China) came to the U.S. in the 1980s. By anyone's reasonable measure, both have achieved the American Dream. However, their dream as scientists remained at arm's length. more info >> |
|
| Monday, February 1, 2021 |
|
|
Eisai to Launch Parkinson's Disease Treatment Equfina in South Korea |
| Eisai Co., Ltd. announced today that Eisai Korea Inc., Eisai's subsidiary in South Korea, has launched the Parkinson's disease treatment Equfina (safinamide mesilate, "safinamide"). This is the first launch of Equfina in the Asian region excluding Japan. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
DataBurning and Vumonic Announce Strategic Partnership for India E-Receipt Data
Apr 30, 2025 13:23 HKT/SGT
|
|
|
Ministry of Hajj and Umrah Emphasizes: 'No Hajj Without a Permit'
Apr 30, 2025 09:30 HKT/SGT
|
|
|
Melbourne's Deputy Lord Mayor shares city's path forward at PropertyGuru Asia Property Awards (Australia) launch
Apr 29, 2025 23:58 HKT/SGT
|
|
|
Katalon Officially Launches TrueTest(TM) - The First AI-Native Testing System That Thinks Like a Tester and Learns from Users
Apr 29, 2025 22:00 HKT/SGT
|
|
|
Global Sports Brand U.S. Polo Assn. Delivers Record $2.5 Billion in Retail Sales for 2024, Targets $3 Billion and 1,500 U.S. Polo Assn. Stores
Apr 29, 2025 19:00 HKT/SGT
|
|
|
Mitsubishi Shipbuilding Holds Christening and Launch Ceremony of Large Car Ferry KEYAKI in Shimonoseki
Apr 29, 2025 17:24 JST
|
|
|
Open Dialogue 'Future of the World. New Platform for Global Growth' Launches at Russia National Centre 
Apr 29, 2025 15:00 HKT/SGT
|
|
|
The Apipatana Foundation Donates S$50,000 to Support Lower-Income Students in Singapore
Apr 29, 2025 15:00 HKT/SGT
|
|
|
HKTDC's April lifestyle fairs open today
Apr 29, 2025 12:42 HKT/SGT
|
|
|
HydroFleet Propels Hydrogen Revolution Forward With HTWO Logistics Collaboration in Savannah, GA
Apr 29, 2025 09:10 HKT/SGT
|
|
|
Azurite Medical and Wellness Launches Revolutionary Luxury Surgical Retreat Concept in Global Medical Tourism Market
Apr 29, 2025 02:09 HKT/SGT
|
|
|
Hong Kong International Licensing Show and Asian Licensing Conference Open Today
Apr 28, 2025 22:46 HKT/SGT
|
|
|
Hung Fook Tong Partners with Nutribite to Launch AI-Powered Personalised Healthy Meal Service
Apr 28, 2025 15:51 HKT/SGT
|
|
|
Q2 Metals Extends Mineralized Zone Strike Length to 1.5 Kilometres and Concludes the 2025 Winter Program at the Cisco Lithium Project in Quebec, Canada
Apr 28, 2025 15:05 HKT/SGT
|
|
|
NEC DGDF Headquarters relocates to Zurich to accelerate growth and enhance management globally
Apr 28, 2025 16:03 JST
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
